← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Medarex, Inc.
Princeton, NJ
$8,050,440
Total funding
6
Grants
Funding over time
peak $1.3M · FY2005–06$2M$1.5M$1M$500K$0
'05
'06
Funding mix
By agency
NIH$8,050,440 · 6
By mechanism
UC1$4,863,738 · 1
U01$2,334,044 · 1
R43$508,908 · 2
R42$243,750 · 1
R41$100,000 · 1
Investigators at Medarex, Inc.
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Largest grants
Fully Human Anti-Anthrax Toxin MAbs: Product Development$4,863,738
UC1 · FY2004 · AI
Development of Fully Human mAbs as Anthrax Antitoxins$786,931
U01 · FY2005 · AI
Development of Fully Human mAbs as Anthrax Antitoxins$781,093
U01 · FY2004 · AI
Development of Fully Human mAbs as Anthrax Antitoxins$766,020
U01 · FY2006 · AI
An improved targeted vaccine strategy against anthrax$408,908
R43 · FY2005 · AI
BISPECIFIC ANTIBODY THERAPY FOR NONHODGKINS LYMPHOMA$243,750
R42 · FY2000 · CA
Novel Immunotoxins for Depletion of Dendritic Cells$100,000
R41 · FY2005 · HL
TARGETED IMMUNOTHERAPY FOR TUMOR EXPRESSING GRP RECEPTOR$100,000
R43 · FY2000 · AI